Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02699567 · ClinicalTrials.gov registry record
CD36 and Human Fat Taste Perception
A clinical trial, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 97
- Enrollment target
NCT02699567: Completed study, sponsored by Washington University School of Medicine.
NCT02699567 is a clinical trial that has completed, run by Washington University School of Medicine. The registered enrollment target is 97 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02699567 has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 97 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of common human variants in in taste related genes, such as CD36 gene, a putative fat taste receptor, affect fat taste perception.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2011-11 |
| Est. Completion | 2014-07 |
What the finished NCT02699567 record still lists
NCT02699567 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 97 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT02699567 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02699567 about?
NCT02699567 is a clinical study titled "CD36 and Human Fat Taste Perception". The purpose of this study is to determine the effect of common human variants in in taste related genes, such as CD36 gene, a putative fat taste receptor, affect fat taste perception.
What is the current status of trial NCT02699567?
This trial is currently completed. The enrollment target is 97 participants. The study started on 2011-11. Estimated completion is 2014-07.
What interventions are being tested in trial NCT02699567?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT02699567?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03948490 · 97 participants · NA
Rehabilitation and Longitudinal Follow-up of Cognition in Adult Lower Grade Gliomas
- NCT04140487 · 97 participants · Phase 1
Azacitidine, Venetoclax, and Gilteritinib in Treating Patients With Recurrent/Refractory FLT3-Mutated Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or High-Risk Myelodysplastic Syndrome/Myeloproliferative Neoplasm
- NCT04196413 · 97 participants · Phase 1
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
- NCT05223816 · 97 participants · Phase 2
An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia